<DOC>
	<DOC>NCT00473525</DOC>
	<brief_summary>The purpose of this Phase 2a study is to evaluate the efficacy, safety and tolerability, of multiple parallel doses of PF-00734200 following oral administration to adult human subjects with T2DM who currently are on a stable dose of metformin.</brief_summary>
	<brief_title>12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diagnosis of type 2 diabetes Hb1AC &gt;7%11% inclusive Male and females 1870; females must be postmenopausal On a stable dose of metformin hydrochloride Medical history of stroke, unstable angina, heart attack within one year of enrollment, and alcohol dependency or recent drug abuse. Women of childbearing potential, pregnant or nursing Evidence of diabetic complications with significant endorgan damage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>